Dose normalization [Study Per­for­mance]

posted by Relaxation  – Germany, 2021-05-27 15:29 (152 d 16:58 ago) – Posting: # 22373
Views: 776

» will not receive the actual dose, but will receive a smaller dose when assessing BD / BE (2x2x2) design)?

Hello yura.

I am sorry, but I am a little bit in a hurry and just wanted to start the answers here with one single comment.
As you are in a cross-over situation and assuming that the dose (BSA) of a subject will not change between periods, there is no need for a dose-adjustment with regard to the treatment comparison. Or the other way around: as you compare intraindividually the dose-adjustment would cancel out anyway.

Best regards!

Complete thread:

Activity
 Admin contact
21,758 posts in 4,550 threads, 1,544 registered users;
online 9 (0 registered, 9 guests [including 5 identified bots]).
Forum time: Wednesday 08:28 CEST (Europe/Vienna)

There ain’t no rules around here!
We’re trying to accomplish something!    Thomas Alva Edison

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5